The evolution of surgical treatment pancreatic cancer

The constant increase in the incidence of malignant neoplasms of the pancreas forces researchers to continue searching for the most effective methods of their diagnosis and treatment. The structure of ductal adenocarcinoma is found in 80-90% of all exocrine tumors of the pancreas. A key component of the diagnosis is the determination of further treatment tactics. A screening method for diagnosing pancreatic cancer is multispiral computed tomography. Radioimmunochemical tests of blood serum for 2 antigens - carbohydrate antigen (CA 19-9), cancer embryonic antigen are of practical importance among laboratory parameters. Currently, systemic chemotherapy for pancreatic cancer is ineffective: the response to treatment is observed in less than 20% of patients, with a median life expectancy of about 6 months. However, studies by a number of authors have proven that adjuvant treatment, including chemotherapy and radiation therapy, increases long-term survival. The current trend in pancreatic surgery is to move away from radicalism towards organ-preserving modifications of total duodenopancreatectomy, pancreatoduodenal resection. The problem of treating pancreatic cancer should be solved by combining the principles of selective choice of interventions, as well as determining clear indications for them. The search for new markers of pancreatic cancer screening, increasing the availability of radiation research methods, and the search for new chemotherapy drugs are promising. The search for reasonable options for reconstructive anastomoses remains relevant, allowing to preserve the physiological integrity of the body and, as a result, reduce mortality and the frequency of postoperative complications.